Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00463840 · ClinicalTrials.gov registry record · Phase 1
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer
A Phase 1 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00463840: Clinical Trial Phase 1 study, sponsored by NYU Langone Health.
NCT00463840 is a Phase 1 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 24 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00463840, a Phase 1 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The intention of this trial is to determine the maximum tolerated of the treatment combination and to evaluate its safety and efficacy.
Primary Outcome
This is the number of patients whose tumors are resectable after the combination treatment of 5FU, oxaliplatin, and radiation (RT).
Interventions
- DRUG Oxaliplatin
- RADIATION Radiation
- PROCEDURE Surgery
- DRUG 5FU
- DRUG FOLFOX 6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-06 |
| Est. Completion | 2015-10 |
| Phase | Phase 1 |
Why NCT00463840 stopped before completion
NCT00463840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 5 interventions - of which Oxaliplatin is the first listed.
NCT00463840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00463840 about?
NCT00463840 is a clinical study titled "Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer". The intention of this trial is to determine the maximum tolerated of the treatment combination and to evaluate its safety and efficacy.
What is the current status of trial NCT00463840?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2004-06. Estimated completion is 2015-10.
What interventions are being tested in trial NCT00463840?
The interventions under investigation include: Oxaliplatin (DRUG), Radiation (RADIATION), Surgery (PROCEDURE), 5FU (DRUG), FOLFOX 6 (DRUG).
Who is sponsoring clinical trial NCT00463840?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00463840's enrollment target sits among peer trials
24 1520th of 2000 higher than 405 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia